Kiniksa Pharmaceuticals Ltd (KNSA) — Financial Flexibility Index
Kiniksa Pharmaceuticals Ltd (KNSA) has a Financial Flexibility Index of 0.23x as of March 2026. Free cash flow of $50.36 Million (operating CF $50.20 Million minus capex $161.00K) represents 0% of total liabilities ($219.59 Million). Also explore Kiniksa Pharmaceuticals Ltd (KNSA) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Kiniksa Pharmaceuticals Ltd Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Kiniksa Pharmaceuticals Ltd across 10 annual periods. Check KNSA strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Kiniksa Pharmaceuticals Ltd (2016–2025)
Year-by-year free cash flow to debt coverage for Kiniksa Pharmaceuticals Ltd. For the full company profile including market capitalisation, see Kiniksa Pharmaceuticals Ltd market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.13x | $25.97 Million | $25.69 Million | $196.03 Million | ▼ -27.5% |
| 2024 | 0.18x | $25.97 Million | $25.69 Million | $142.12 Million | ▲ +19.0% |
| 2023 | 0.15x | $13.43 Million | $13.30 Million | $87.48 Million | ▲ +65.0% |
| 2022 | 0.09x | $5.91 Million | $5.81 Million | $63.52 Million | ▲ +104.2% |
| 2021 | -2.22x | $-105.88 Million | $-126.30 Million | $47.76 Million | ▲ +38.9% |
| 2020 | -3.63x | $-136.25 Million | $-136.53 Million | $37.53 Million | ▲ +31.9% |
| 2019 | -5.33x | $-155.17 Million | $-158.37 Million | $29.11 Million | ▼ -200.6% |
| 2018 | -1.77x | $-75.72 Million | $-81.01 Million | $42.70 Million | ▼ -385.2% |
| 2017 | -0.37x | $-50.15 Million | $-50.22 Million | $137.20 Million | ▼ -37.4% |
| 2016 | -0.27x | $-21.86 Million | $-21.87 Million | $82.20 Million | — |